Quantcast
Viewing all articles
Browse latest Browse all 2570

Regeneron and Sanofi Announce Approval of Praluent alirocumab for the Treatment of Hypercholesterolemia in Japan

TARRYTOWN N.Y. and PARIS July 5 2016 PRNewswire &160;Regeneron Pharmaceuticals Inc. NASDAQ REGN and Sanofi today announced that the Ministry of Health Labor and Welfare in Japan has granted marketing and manufacturing authorization for Praluent&174...

Viewing all articles
Browse latest Browse all 2570

Trending Articles